Health & Behavior

Research

The Latest

UC Medical Campus Consortium Named Designated Center to Translate Innovations into Improved Health

A consortium of the five University of California medical campuses at UC San Diego, UC Davis, UC Irvine, UCLA and UC San Francisco has been designated a Center for Accelerated Innovations by the National Heart, Lung and Blood Institute (NHLBI). The designation recognizes the University of California’s potential to translate its leading-edge discoveries into innovative products that benefit patients.

Cancer Cells Propagated from Early Prostate Cancer

A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.

$5.6 Million Grant Renewal Expands Research in Kidney Failure

The National Institute of Diabetes and Digestive and Kidney Diseases – part of the National Institutes of Health – has renewed a grant shared by the University of California, San Diego and the University of Alabama at Birmingham Schools of Medicine. The five-year, $5.64 million renewal will extend and expand research into acute kidney failure, or acute kidney injury, which kills 70 to 80 percent of patients in intensive care units who develop the disease.

Reassuring Findings for Mothers Who Have Flu Shot During Pregnancy

Researchers from the University of California, San Diego School of Medicine and Boston University, in collaboration with the American Academy of Allergy Asthma and Immunology (AAAAI), have found evidence of the H1N1 influenza vaccine’s safety during pregnancy.

Data from Across Globe Defines Distinct Kawasaki Disease Season

After more than four decades of research, strong evidence now shows that Kawasaki disease has a distinct seasonal occurrence shared by regions across the Northern hemisphere.

UC San Diego Bruce Gorder 5K Walk For Melanoma Celebrates 20 Years on Oct. 19

By the time Bruce Gorder was diagnosed with melanoma, it was too late. At just 37, his life was taken by the deadly disease, leaving his wife, young daughter and family devastated. Yet out of the tragedy a new initiative was borne—one that could potentially save lives.